STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] Rocket Companies, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

This Amendment No. 4 to a Schedule 13D reports that ValueAct-related entities together hold 41,509,252 shares of Rocket Companies, Inc. (Class A), equal to approximately 4.3% of the company's Common Stock on the basis of 965,183,901 total shares. The aggregate purchase price for the shares held by ValueAct Capital Master Fund is reported as approximately $509,080,275.68. The filing states that 16,113,625 of these shares were acquired effective October 1, 2025 in connection with Rocket's acquisition of Mr. Cooper, which increased ValueAct Master Fund's beneficial ownership. The Reporting Persons further state that as of October 1, 2025 they have ceased to be beneficial owners of more than 5% of Rocket's Common Stock, terminating their Schedule 13D filing obligation.

Positive

  • Acquisition-driven increase: ValueAct Master Fund acquired 16,113,625 shares effective October 1, 2025 via the Mr. Cooper transaction.
  • Clear cost disclosure: The aggregate purchase price for ValueAct Master Fund's holdings is stated as $509,080,275.68.

Negative

  • Below 5% threshold: Reporting Persons confirm they have ceased to be beneficial owners of more than 5% as of October 1, 2025, ending their Schedule 13D obligation.
  • Shared, not sole, control: All reported voting and dispositive power is shared (no sole voting or dispositive power reported).

Insights

ValueAct holds 41.5M RKT shares (4.3%), acquired about $509.1M; ownership falls below 5% as of Oct 1, 2025.

ValueAct Master Fund's stake of 41,509,252 shares (approx. 4.3%) is explicitly tied to 16,113,625 shares received in connection with Rocket's acquisition of Mr. Cooper effective October 1, 2025. The filing lists the $509,080,275.68 aggregate purchase price for the Master Fund's position, paid from working capital.

Because the Reporting Persons state they have "ceased to be beneficial owners of more than five percent" as of October 1, 2025, their Schedule 13D obligations terminate; this is the single concrete, monitorable disclosure in the filing.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
(4) See Item 3 (8, 10, 11) See Item 2 and 5 (14) LLC


SCHEDULE 13D




Comment for Type of Reporting Person:
(4) See Item 3 (8, 10, 11) See Item 2 and 5


SCHEDULE 13D




Comment for Type of Reporting Person:
(4) See Item 3 (8, 10, 11) See Item 2 and 5


SCHEDULE 13D




Comment for Type of Reporting Person:
(4) See Item 3 (8, 10, 11) See Item 2 and 5 (14) LLC


SCHEDULE 13D




Comment for Type of Reporting Person:
(4) See Item 3 (8, 10, 11) See Item 2 and 5


SCHEDULE 13D




Comment for Type of Reporting Person:
(4) See Item 3 (8, 10, 11) See Item 2 and 5


SCHEDULE 13D




Comment for Type of Reporting Person:
(4) See Item 3 (8, 10, 11) See Item 2 and 5 (14) LLC


SCHEDULE 13D


VA Partners I, LLC
Signature:/s/ Jason B. Breeding
Name/Title:Jason B. Breeding, Authorized Signatory
Date:10/03/2025
ValueAct Capital Master Fund, L.P.
Signature:/s/ Jason B. Breeding
Name/Title:Jason B. Breeding, Authorized Signatory, VA Partners I, LLC, its General Partner
Date:10/03/2025
ValueAct Capital Management, L.P.
Signature:/s/ Jason B. Breeding
Name/Title:Jason B. Breeding, Authorized Signatory, ValueAct Capital Management, LLC, its General Partner
Date:10/03/2025
ValueAct Capital Management, LLC
Signature:/s/ Jason B. Breeding
Name/Title:Jason B. Breeding, Authorized Signatory
Date:10/03/2025
ValueAct Holdings, L.P.
Signature:/s/ Jason B. Breeding
Name/Title:Jason B. Breeding, Authorized Signatory, ValueAct Holdings GP, LLC, its General Partner
Date:10/03/2025
ValueAct Holdings II, L.P.
Signature:/s/ Jason B. Breeding
Name/Title:Jason B. Breeding, Authorized Signatory, ValueAct Holdings GP, LLC, its General Partner
Date:10/03/2025
ValueAct Holdings GP, LLC
Signature:/s/ Jason B. Breeding
Name/Title:Jason B. Breeding, Authorized Signatory
Date:10/03/2025

FAQ

What stake does ValueAct report in Rocket Companies (RKT)?

The Reporting Persons report beneficial ownership of 41,509,252 shares, representing approximately 4.3% of Rocket's Common Stock.

How much did ValueAct pay for its Rocket (RKT) position?

The aggregate purchase price for the Common Stock held by ValueAct Capital Master Fund is approximately $509,080,275.68.

When did ValueAct acquire the additional Rocket (RKT) shares from the Mr. Cooper deal?

ValueAct Master Fund acquired 16,113,625 shares effective October 1, 2025 as a result of Rocket's acquisition of Mr. Cooper.

Does ValueAct still have to file Schedule 13D for Rocket (RKT)?

No. The filing states that as of October 1, 2025 the Reporting Persons have ceased to be beneficial owners of more than 5%, terminating their Schedule 13D obligation.

Who certified the Schedule 13D/A filing for ValueAct?

The signatures and certifications are provided by Jason B. Breeding as Authorized Signatory for the reporting entities, dated October 3, 2025.
Rocket Companies Inc

NYSE:RKT

RKT Rankings

RKT Latest News

RKT Latest SEC Filings

RKT Stock Data

49.11B
951.55M
1.25%
94.42%
5.6%
Mortgage Finance
Mortgage Bankers & Loan Correspondents
Link
United States
DETROIT